SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Eli Lilly
Eli Lilly
Page 4 of 7
Aging Well
Eli Lilly cracks down on the use of weight loss drugs Mounjaro and Zepbound for ‘cosmetic’ reasons instead of for diabetes and obesity
By
Alexa Mikhail
January 4, 2024
Newsletters
Career advice from the CFOs of Dell, Eli Lilly, and Marriott—3 women who have each spent 20-plus years climbing the ladder at one company
By
Sheryl Estrada
December 4, 2023
Health
Pfizer rocked by failure of weight-loss pill set to compete with lucrative rivals Ozempic and Mounjaro
By
Madison Muller
and
Bloomberg
December 1, 2023
Health
Wegovy maker Novo Nordisk could make prices flexible—without cutting them—to persuade more health systems to cover the weight-loss drugs
By
Prarthana Prakash
November 27, 2023
Retail
Scientists have discovered a new benefit to Novo Nordisk’s weight-loss drug Wegovy: It can cut heart-related deaths by 20%, drugmaker reports
By
Prarthana Prakash
November 13, 2023
Health
FDA approves yet another weight loss drug to compete against blockbuster sellers Ozempic and Wegovy
By
Madison Muller
and
Bloomberg
November 8, 2023
Health
Novo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze
By
Prarthana Prakash
November 3, 2023
Health
New weight-loss blockbuster drug emerges from study showing Mounjaro helps people lose 25% of their body weight or 60 pounds on average
By
Jonel Aleccia
and
The Associated Press
October 15, 2023
Tech
TikTok’s hidden ‘Ozempic economy,’ where weight-loss influencers trade referrals for drug discounts and cash
By
Alexandra Sternlicht
September 19, 2023
Health
Blockbuster weight loss drugs Ozempic and Wegovy cost Americans up to 10 times more than what other countries pay, research shows
By
Christiaan Hetzner
August 18, 2023
Success
Eli Lilly’s CEO pinpoints the 3-prong problem big execs face with remote work
By
Jane Thier
June 24, 2023
Health
Experimental Alzheimer’s drug 35% more effective than placebo: Eli Lilly
By
The Associated Press
May 3, 2023
Health
Powerful new obesity drug from Eli Lilly expected to be one of best selling drugs of all time, with sales over $50bn a year
By
Jonel Aleccia
and
The Associated Press
April 27, 2023
Politics
Biden team, pharmaceutical giant Eli Lilly condemn new Indiana abortion ban: ‘We will be forced to plan for more employment growth outside our home state’
By
The Associated Press
August 6, 2022
Health
This Nashville-based VC is addressing racial inequalities in health care with a fund backed by Eli Lilly, Cardinal Health, and others
By
Blake Farmer
and
Kaiser Health News
February 24, 2022
Most Popular
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
By
Jason Ma
Success
Be careful boomers, your Gen Z coworker may be recording you — 9-to-5s aren’t just about climbing the ladder, they’re...
By
Jessica Coacci
Success
This Stanford computer science professor went to written exams 2 years ago because of AI. He says his students insisted...
By
Nick Lichtenberg